Name: Cereno Scientific’s CEO on novel therapies for rare diseases
Uploaded: 2024-11-06T08:24:04+01:00
Channel: Fanny Amoranitis
Description: Cereno's CEO Sten R. Sörensen tells us more about the company and what the future holds.

Cereno Scientific’s CEO on novel therapies for rare diseases

6 November, 2024

Cereno granted approval to initiate Phase I trial with CS014

Cereno’s CEO: “CS014 adds potential for cardiovascular disease patients”

20 June, 2024

Tag: HDAC inhibition

Cereno Scientific’s CEO on novel therapies for rare diseases

Cereno’s CEO: “CS014 adds potential for cardiovascular disease patients”